EDMOND WHITE: Open Payments
NPI 1720225949 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 28 payments from 11 companies in 2025. Trend: 2023 $21 · 2024 $0 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $215 |
| Amgen Inc. | 7 | $164 |
| ABBVIE INC. | 2 | $41 |
| BETA BIONICS, INC. | 1 | $33 |
| Abbott Laboratories | 1 | $30 |
| Viatris Specialty LLC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| CARDIVA MEDICAL, INC. | 1 | $19 |
Products named: OTEZLA, Wegovy, QULIPTA, iLet Bionic Pancreas, ETERNA, YUPELRI, Rybelsus, TREMFYA.
Industry payments across NC — which companies pay providers there.
